Literature DB >> 7428303

The source of serum ferritin during infection. Studies with concanavalin A--Sepharose absorption.

G Birgegård.   

Abstract

1. Serum samples were collected from ten patients hospitalized for acute infections and from a control group of seven normal subjects. Tissue ferritin was obtained by purification of ferritin from normal human liver and from the ferritin standard of a commercially available assay kit. 2. The serum and tissue samples were incubated with concanavalin A--Sepharose, which has the ability to bind normal serum ferritin. 3. Concanavalin A, a plant lectin which binds to glucose, can be coupled to Sepharose particles and by incubation and centrifugation ferritin in normal serum can be absorbed to about 70%. The serum and tissue samples were incubated with concanavalin A--Sepharose and the ferritin content was measured before and after. 4. It was found that ferritin in the serum of patients with acute infections was absorbed to the same extent as in normal serum (about 80%), irrespective of the initial value. Only about 20% of the tissue ferritin was absorbed. 5. It is concluded that the ferritin in serum during infection is of the same glucosylated type as the ferritin normally present in serum, whereas intracellular ferritin is not glycosylated. This indicates that the elevation of serum ferritin during infection is caused by a release along the normal pathways, i.e. an augmented synthesis, not by leakage from damaged cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428303     DOI: 10.1042/cs0590385

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

Review 1.  Plasma ferritin determination as a diagnostic tool.

Authors:  C A Finch; V Bellotti; S Stray; D A Lipschitz; J D Cook; M J Pippard; H A Huebers
Journal:  West J Med       Date:  1986-11

2.  Binding of serum ferritin to concanavalin A in patients with iron overload and with chronic liver disease.

Authors:  R W Chapman; A Gorman; M Laulicht; M A Hussain; S Sherlock; A V Hoffbrand
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

Review 3.  Clinical pharmacokinetics of iron preparations.

Authors:  E Harju
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

4.  Protective effect of tissue ferritins in experimental Escherichia coli infection of mice in vivo.

Authors:  P Lipiński; Z Jarzabek; S Broniek; T Zagulski
Journal:  Int J Exp Pathol       Date:  1991-12       Impact factor: 1.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.